Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Disitamab Vedotin Plus Penpulimab and Cisplatin in Advanced Gastric Cancer

NCT05313906 is registered in ClinicalTrials.gov with Henan Cancer Hospital as lead sponsor.

NCT NCT05313906
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05313906 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Disitamab Vedotin Plus Penpulimab and Cisplatin in Advanced Gastric Cancer
Lead sponsor
Henan Cancer Hospital
Phase
Phase 2
Overall status
Unknown status
Start date
May 7, 2022
Completion date
April 30, 2024
Enrollment
40 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

advanced gastric carcinoma, her2-positive gastric cancer